- Home
- APGE vs CRNX Comparison
APGE vs CRNX Comparison
Compare APGE & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- CRNX
- Stock Information
- Founded
- APGE 2022
- CRNX 2008
- Country
- APGE United States
- CRNX United States
- Employees
- APGE N/A
- CRNX N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- APGE Health Care
- CRNX Health Care
- Exchange
- APGE Nasdaq
- CRNX Nasdaq
- Market Cap
- APGE 2.4B
- CRNX 2.8B
- IPO Year
- APGE 2023
- CRNX 2018
- Fundamental
- Price
- APGE $54.65
- CRNX $42.99
- Analyst Decision
- APGE Strong Buy
- CRNX Buy
- Analyst Count
- APGE 8
- CRNX 12
- Target Price
- APGE $94.63
- CRNX $74.45
- AVG Volume (30 Days)
- APGE 972.3K
- CRNX 1.4M
- Earning Date
- APGE 11-12-2025
- CRNX 11-06-2025
- Dividend Yield
- APGE N/A
- CRNX N/A
- EPS Growth
- APGE N/A
- CRNX N/A
- EPS
- APGE N/A
- CRNX N/A
- Revenue
- APGE N/A
- CRNX $1,392,000.00
- Revenue This Year
- APGE N/A
- CRNX $420.79
- Revenue Next Year
- APGE N/A
- CRNX $993.85
- P/E Ratio
- APGE N/A
- CRNX N/A
- Revenue Growth
- APGE N/A
- CRNX 0.51
- 52 Week Low
- APGE $26.20
- CRNX $24.10
- 52 Week High
- APGE $63.50
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- APGE 61.53
- CRNX 55.24
- Support Level
- APGE $54.80
- CRNX $41.12
- Resistance Level
- APGE $57.00
- CRNX $44.70
- Average True Range (ATR)
- APGE 2.81
- CRNX 2.09
- MACD
- APGE -0.36
- CRNX -0.25
- Stochastic Oscillator
- APGE 43.45
- CRNX 51.24
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.